The effects of an open design on trial participant recruitment, compliance and retention – a randomized controlled trial comparison with a blinded, placebo-controlled design
- 1 December 2004
- journal article
- clinical trial
- Published by SAGE Publications in Clinical Trials
- Vol. 1 (6), 490-498
- https://doi.org/10.1191/1740774504cn053oa
Abstract
Background In randomized trials there may be no overriding reason whether or not to have a placebo control. Purpose We assessed the effects of an open trial design (no placebo and people know what tablets they are given) compared with a blinded, placebo-controlled design on recruitment, compliance and retention within a randomized trial of secondary osteoporotic fracture prevention. Methods We undertook a randomized controlled comparison nested within a placebo-controlled trial of nutritional supplementation amongst people aged 70 years or over who had previously sustained a fracture, recruited in a UK teaching hospital. Randomization was 2: 1 in favour of the blinded, placebo-controlled trial design. Results From 180 eligible participants randomized to receive information based on the open trial design, 134 (74.4%) consented to take part, compared with 233 (65.1%) of 358 people randomized to the blinded, placebo-controlled design (difference 9.4%, 95% confidence interval 1.3–17.4%). Reluctance to take a placebo and the desire to know tablet allocation were reasons given for not taking part in the blinded, placebo-controlled design. There was no significant difference in tablet compliance. Open trial participants were more likely to remain in the trial for one year (difference 13.9%, 95% confidence interval 3.1–24.6%), mainly reflecting the high retention of the open trial no tablet group compared to the open trial tablet group (difference 23.6%, 95% confidence interval 11.9–35.2%). The odds ratio for reporting an adverse event in the open trial compared to the blinded, placebo-controlled design was 0.64 (95% confidence interval 0.28–1.49), and for reporting a fracture was 0.81 (0.36–1.85). Conclusions We conclude that using an open trial design may enhance participant recruitment and retention and thus improve generalizability and statistical power, but withdrawal rates may differ between the study allocations and may threaten the internal validity of the trial.Keywords
This publication has 8 references indexed in Scilit:
- Attitudes of Patients With Schizophrenia Toward Placebo-Controlled Clinical TrialsBritish Journal of Psychology, 2003
- The method of minimization for allocation to clinical trialsControlled Clinical Trials, 2002
- Surveys identify barriers to participation in clinical trials.JNCI Journal of the National Cancer Institute, 2000
- Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based studyBMJ, 1999
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998
- Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)American Journal of Hypertension, 1996
- Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitmentCancer, 1995
- Minimization: A new method of assigning patients to treatment and control groupsClinical Pharmacology & Therapeutics, 1974